What amount sold does Aviette BioProcessing, LLC report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Aviette BioProcessing, LLC's most recent SEC filing?

Aviette BioProcessing, LLC's most recent Form D filing was on 2020-09-08.

What type of securities does Aviette BioProcessing, LLC offer?

Aviette BioProcessing, LLC's SEC Form D filings indicate equity offerings.

Aviette BioProcessing, LLC

CIK: 0001822940·Manufacturing·FRANKLIN, KY·Limited Liability Company·Founded 2020

Reported Sold

Total Filings

Identified Offerings

Last Filed

Sep 8, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Manufacturing industry

SEC EDGAR

Offering filing timeline

Sep 8, 2020Form D — New notice

Reported sold: $0 · Target: $2,000,000

Rule 506(b)·0 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

No Revenues

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Mark John Loik

Related Person

Appears on 1 filing

Travis Newton Creed

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 8, 2020	New	$2,000,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Lentek, LLC

Manufacturing

Offering target: $1,035,000

Filed Oct 26, 2026